Postpartum thyroiditis epidemiology and demographics: Difference between revisions

	Postpartum thyroiditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Postpartum Thyroiditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Postpartum thyroiditis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Postpartum thyroiditis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Postpartum thyroiditis epidemiology and demographics
CDC on Postpartum thyroiditis epidemiology and demographics
Postpartum thyroiditis epidemiology and demographics in the news
Blogs on Postpartum thyroiditis epidemiology and demographics
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Postpartum thyroiditis epidemiology and demographics

VisualWikitext

Revision as of 01:01, 26 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Epidemiology and Demographics

Incidence

In 2012, the incidence of PPT was estimated to be 1600 to 18200 cases per 100,000 women.
Incidence of PPT increase with patients having type 1 DM up to 25000 per 100,000 women.
Incidence of PPT increase with subsequent pregnancies.
Incidence of PPT increase with postive TPO antibodies and subsequent pregnancies to approximatrly 70000 cases per 100,000 women.
In 2000, the incidence of PPT was established to be approximately 7800 cases per 100,000 Mediterranean population.

Prevalence

In 2012,The prevalence of PPT was estimated to be from 1000 to 20000, with a mean prevalence of 5000 cases per 100,000 women.

Case-fatality rate

No data available

Age

PPT occurs in women in child bearing age.

Race

PPT usually affects individuals of the Mediterranean population race. Mongolian race is usually less effected.

Region

The majority of PPT cases are reported Europe and Japan.

Developed Countries

USA 9000 cases per 100,000 women.

Britain 16700 cases per 100,000 women.

Italy 8700 cases per 100,000 women.

Developing Countries

India 7000 cases per 100,000 women.

Japan 5300 to 21000 cases per 100,000 women.

Thailand 1100 cases per 100,000 women.

References

Template:WH Template:WS DIANA L. LEAROYD, HEDY Y. M. FUNG, and ALAN M. McGREGOR. Thyroid. March 2009, 2(1): 73-80.

Anna Lucas, Eduarda Pizarro, Maria Luisa Granada, Isabel Salinas, Mario Foz, and Anna Sanmarti. Thyroid. January 2009, 10(1): 71-77. https://doi.org/10.1089/thy.2000.10.71

https://www.thyroid.org/wp-content/uploads/patients/brochures/Postpartum_Thyroiditis_brochure.pdf

J Clin Endocrinol Metab. 2012 Feb; 97(2):334-42.

Amino N, Tada H & Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999 9 705–713.

@@ Line 7: / Line 7: @@
 ==Epidemiology and Demographics==
 ===Incidence===
-*The incidence of PPT is approximately 5400  per 100000 pregnancies  worldwide.
+*In 2012, the incidence of PPT was estimated to be 1600 to 18200 cases per 100,000 women.
-*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
+*Incidence of PPT increase with patients having type 1 DM  up to 25000 per 100,000 women.
+*Incidence of PPT increase with subsequent pregnancies.
+*Incidence of PPT increase with postive TPO antibodies and subsequent pregnancies to approximatrly 70000 cases per 100,000 women.
+*In 2000, the incidence of PPT was established to be approximately 7800 cases per 100,000 Mediterranean population.
 ===Prevalence===
-*The prevalence of PPT is approximately 7.8% pregnencies worldwide.
+*In 2012,The prevalence of PPT was estimated to be from 1000 to 20000, with a mean prevalence of 5000 cases per 100,000 women.
-*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
-*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 ===Case-fatality rate===
-*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
+*No data available
-*The case-fatality rate of [disease name] is approximately [number range].
 ===Age===
-*Patients of all age groups may develop [disease name].
+*PPT occurs in women in child bearing age.
-*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
-*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
-*[Chronic disease name] is usually first diagnosed among [age group].
-*[Acute disease name] commonly affects [age group].
 ===Race===
-*There is no racial predilection to [disease name].
+*PPT usually affects individuals of the Mediterranean population race. Mongolian race is usually less effected.
-*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 ===Region===
-*The majority of [disease name] cases are reported in [geographical region].
+*The majority of PPT cases are reported Europe and Japan.
-*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
+===Developed Countries===
+USA 9000 cases per 100,000 women.
-===Developed Countries===
+Britain 16700 cases per 100,000 women.
+Italy 8700 cases per 100,000 women.
 ===Developing Countries===
+India 7000 cases per 100,000 women.
+Japan 5300 to 21000 cases per 100,000 women.
+Thailand 1100 cases per 100,000 women.
@@ Line 46: / Line 49: @@
 DIANA L. LEAROYD, HEDY Y. M. FUNG, and ALAN M. McGREGOR. Thyroid. March 2009, 2(1): 73-80.
-Anna Lucas, Eduarda Pizarro, Maria Luisa Granada, Isabel Salinas, Mario Foz, and Anna Sanmarti. Thyroid. January 2009, 10(1): 71-77. <nowiki>https://doi.org/10.1089/thy.2000.10.71</nowiki>
+Anna Lucas, Eduarda Pizarro, Maria Luisa Granada, Isabel Salinas, Mario Foz, and Anna Sanmarti. Thyroid. January 2009, 10(1): 71-77. https://doi.org/10.1089/thy.2000.10.71
+https://www.thyroid.org/wp-content/uploads/patients/brochures/Postpartum_Thyroiditis_brochure.pdf
+J Clin Endocrinol Metab. 2012 Feb; 97(2):334-42.
+Amino N, Tada H & Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999 9 705–713.
 [[Category: (name of the system)]]